Quanterix Study Explores Usefulness of NfL as Biomarker Across Range of Neurological Conditions Premium The researchers found that the blood-based marker, a key product for vendor Quanterix, could aid in the diagnosis and management of several diseases. People in the News: New Appointments at Illumina, Pacific Biosciences, Qiagen, Quanterix, More Quanterix Q1 Revenues up 73 Percent The company posted Q1 revenues of $27.2 million, up from $15.7 million in Q1 2020 and above the consensus Wall Street estimate of $21.4 million. GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month. Investor Interest in Proteomics Rising on New, Improving Technologies Premium Investor appetite for proteomics is growing, driven in part by improvements in mass spec but more significantly by new tech from early-stage firms soon to go public. Mar 2, 2021 Quanterix Q4 Revenues Up 64 Percent Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Feb 12, 2021 Quanterix, WuXi AppTec to Open Joint Lab in Shanghai Feb 4, 2021 Quanterix Prices $250M Public Stock Offering Jan 14, 2021 JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Jan 13, 2021 Quanterix Provides Preliminary Results Projecting Q4 Revenues of $24M to $26M Nov 20, 2020 People in the News: New Appointments at Natera, Quanterix, Sophia Genetics, More Nov 6, 2020 Quanterix Q3 Revenues Increase 111 Percent on License, Grant Revenue Oct 6, 2020 RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing Aug 14, 2020 In Brief This Week: BGI, Illumina, Pacific Biosciences, Oxford Nanopore, Co-Diagnostics, More Aug 7, 2020 Quanterix Prices $85M Public Stock Offering Aug 4, 2020 Quanterix Q2 Revenues Down 3 Percent, Beating Wall Street Estimate May 11, 2020 Quanterix Licenses Multiplex SARS-CoV-2 Serology Test From Brigham and Women's May 6, 2020 Quanterix Q1 Revenues Up 27 Percent Apr 17, 2020 Proteomics Firms Redirect Immuno-oncology Tools to COVID-19 Research Mar 9, 2020 Quanterix Q4 Revenues Up 46 Percent Jan 16, 2020 JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Nov 6, 2019 Quanterix Q3 Revenues Increase 41 Percent Oct 24, 2019 Inventor of Quanterix Tech Exploring Point-of-Care Simoa Device for Tuberculosis Detection Premium Aug 13, 2019 Quanterix Closes $69M Stock Offering Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.